Aptorum Group shareholders approved proposed DiamiR merger at meeting

• At a shareholder meeting held June 9, 2026, Aptorum investors adopted the proposed all-stock merger with DiamiR Biosciences.
• The vote authorizes the transaction under which DiamiR would become a wholly owned subsidiary, subject to remaining customary closing conditions.
• The merger has not yet been completed; the companies expect to close it before fiscal 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptorum Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-067085), on June 10, 2026, and is solely responsible for the information contained therein.